We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

195 hedge funds and large institutions have $51M invested in Editas Medicine in 2025 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 61 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% more call options, than puts

Call options by funds: $668K | Put options by funds: $339K

6% less funds holding

Funds holding: 207 → 195 (-12)

8.81% less ownership

Funds ownership: 61.84% → 53.03% (-8.8%)

21% less capital invested

Capital invested by funds: $64.8M → $51M (-$13.8M)

28% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 61

32% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 34

Holders
195
Holders Change
-12
Holders Change %
-5.8%
% of All Funds
2.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
44
Reduced
61
Closed
34
Calls
$668K
Puts
$339K
Net Calls
+$329K
Net Calls Change
+$321K

Top Buyers

Rank Fund Capital Flow
1
UBS AM
UBS AM
Illinois
+$2.1M
2
Morgan Stanley
Morgan Stanley
New York
+$1.65M
3
Bank of America
Bank of America
North Carolina
+$1.6M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$946K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$822K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$3.62M
2
Goldman Sachs
Goldman Sachs
New York
-$1.79M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$1.65M
4
MAM
Monaco Asset Management
Monaco
-$1.36M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
176
Parallel Advisors
California
$70 – – –
DIP
177
DT Investment Partners
Pennsylvania
$63 – – –
GWP
178
Gen-Wealth Partners
Michigan
$61 – – –
CFFP
179
Center for Financial Planning
Michigan
$58 – – –
NRG
180
Nemes Rush Group
Michigan
$58 – – –
MWM
181
MorganRosel Wealth Management
Colorado
$46 +$59 +40 New
NSIM
182
North Star Investment Management
Illinois
$44 – – –
CTA
183
Colonial Trust Advisors
South Carolina
$35 – – –
CA
184
Clearstead Advisors
Ohio
$29 -$75 -51 -67%
WT
185
Whittier Trust
California
$28 -$427 -290 -92%
MCM
186
MAI Capital Management
Ohio
$26 – – –
HI
187
Harbour Investments
Wisconsin
$22 – – –
RWML
188
RAFFA WEALTH MANAGEMENT, LLC
District of Columbia
$22 – – –
FP
189
Financial Perspectives
Minnesota
$7 – – –
SSB
190
Sandy Spring Bank
Maryland
$3 +$3 +2 New
MA
191
MCF Advisors
Kentucky
$2 – – –
Northwestern Mutual Wealth Management
192
Northwestern Mutual Wealth Management
Wisconsin
$1 – – –
Balyasny Asset Management
193
Balyasny Asset Management
Illinois
– -$1.65M -1,300,604 Closed
MAM
194
Monaco Asset Management
Monaco
– -$1.36M -1,069,732 Closed
WP
195
Woodline Partners
California
– -$1.06M -838,419 Closed
Jacobs Levy Equity Management
196
Jacobs Levy Equity Management
New Jersey
– -$900K -708,409 Closed
TCM
197
Tang Capital Management
California
– -$508K -400,000 Closed
Ameriprise
198
Ameriprise
Minnesota
– -$289K -227,609 Closed
Squarepoint
199
Squarepoint
New York
– -$241K -189,462 Closed
AC
200
Aristides Capital
Kentucky
– -$168K -131,900 Closed
6 7
8
9 10

EDIT Hedge Fund Activity: Q1 2025 in Review

195 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q1 2025, worth a combined $51M — down 21% from $64.8M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of EDIT and 23 opened new positions — a net loss of 11 holders — while 61 trimmed existing stakes and 44 added.

The largest buyer was UBS AM, adding an estimated $2.1M. The largest seller was Millennium Management, cutting an estimated $3.62M.

  • 195 institutional investors held Editas Medicine (EDIT) as of Q1 2025, down from 207 in Q4 2024.
  • Funds reported $51M of Editas Medicine stock for Q1 2025, down 21% quarter-over-quarter.
  • 23 funds opened new Editas Medicine positions in Q1 2025 and 34 closed out, a net change of -11 holders.
  • The largest Editas Medicine buyer in Q1 2025 was UBS AM, an estimated $2.1M added.
  • The largest Editas Medicine seller in Q1 2025 was Millennium Management, an estimated $3.62M sold.

Based on aggregated 13F filings for Q1 2025.